Microlin Bio is an emerging therapeutics company focusing on microRNA and their role in oncology.

Recent News:

March 15, 2016
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech for Alzheimer’s Disease

February 10, 2016
Microlin Bio Signs Exclusive License and Research Agreement With Université Laval to Develop microRNA-Based Treatments for Alzheimer’s Disease

January 14, 2016
Microlin Bio, Inc. Announces Ticker Symbol Change to MICB